1. Hallek M, Bergsagel PL, Anderson KC. Multiple myeloma: increasing evidence for a multistep transformation process. Blood. 1998;91(1):3–21.
2. Chen HF, Wu TQ, Li ZY, Shen HS, Tang JQ, Fu WJ, et al. Extramedullary plasmacytoma in the presence of multiple myeloma: clinical correlates and prognostic relevance. Onco Targets Ther. 2012;5:329–34.
3. Ahnach M, Marouan S, Rachid M, Madani A, Quessar A, Benchekroun S, et al. Extramedullary plasocytoma relapsing at different sites: an unusual presentation. Pan Afr Med J. 2013;14:34–7.
4. Swerdlow S, Campo E, Harris N, Jaffe E, Liperi S, Stein H, et al. WHO classification of tumours of haematopoeitic and lymphoid tissue. 4th ed. Lyon: International Agency for research on Cancer; 2008.
5. Varettoni M, Corso A, Pica G, Mangiacavalli S, Pacutto C, Lazzarino M. Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients. Ann Oncol. 2010;2:325–30.